Clinical Trial Update: A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) [Phase 3]

View source ↗

Summary

A Phase 3 multi-center study evaluated the efficacy and safety of PEP005 (ingenol mebutate) gel for actinic keratosis on the face or scalp. The trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (Ingenol Mebutate) Gel (Ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-21